XORTX Therapeutics Inc. (XRTX)
NASDAQ·Healthcare·Biotechnology
$2.74
-7.74%
Mkt Cap $1.74M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | -$0.84 | -$0.45 | +46.14% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.17 | -$0.13 | +22.20% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.25 | -$0.19 | +24.00% | — | — |
| Q2 2025 May 21, 2025 | — | — | — | -$0.27 | -$1.24 | -359.26% | — | — |
| Q2 2025 May 19, 2025 | — | — | — | -$0.27 | -$0.19 | +29.63% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.29 | -$0.19 | +34.48% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.38 | -$0.20 | +47.80% | — | — |
| Q3 2024 Aug 14, 2024 | — | — | — | -$0.50 | $0.06 | +111.98% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$0.45 | -$1.24 | -176.54% | — | — |
| Q2 2024 Apr 2, 2024 | — | — | — | -$0.68 | -$0.48 | +29.00% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$2.04 | -$6.03 | -195.50% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$1.56 | -$0.81 | +47.98% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$1.31 | -$0.99 | +24.44% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$2.18 | -$1.35 | +38.03% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$1.54 | -$0.81 | +47.31% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.24 | -$0.81 | -237.50% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$1.49 | -$0.72 | +51.77% | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | $5.21 | — | — | — |
| Q4 2021 Nov 29, 2021 | — | — | — | — | -$157.00 | — | — | — |
| Q3 2021 Aug 27, 2021 | — | — | — | — | -$5.25 | — | — | — |